2-Bromo-9,9-dimethyl-9,10-dihydroacridine, 97%, 250mg

(5-(Benzyloxy)-2-methylphenyl)boronic acid, 98%, 1g

4-Bromobenzyl methyl sulfide, 97.0%, 2g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-cyclohexylpropanoic acid, 98%, 5g

Mono-6-O-(p-toluenesulfonyl)-alpha-cyclodextrin>85.0%(HPLC)1g

3-Chloro-4-fluorobenzenesulfonamide, 97.0%, 1g

2,4-Dichloro-6-iodoaniline, 95.0%, 500g

3,5-Diiodo-4-methylbenzaldehyde, 97.0%, 250mg

(R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, 97%, 1g

3-(4-(TRIFLUOROMETHYL)PHENYL)BICYCLO[1.1.1]PENTANE-1-CARBOXYLIC ACID, 95.0%, 100mg

D-Tyrosine, O-(1,1-dimethylethyl)-N-[(phenylmethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1) (9CI), 98%, 1g

8-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-1,4-dioxaspiro[4.5]decane-8-carboxylic acid, 95+%, 250mg

Gel-Blotting-Papiere (GB005), D 1,5 mm, 200 x 200 mm, im Karton, 25 Blatt